The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030
View ORCID ProfileKeri N Althoff, Cameron Stewart, Elizabeth Humes, Lucas Gerace, Cynthia Boyd, Kelly Gebo, Amy C Justice, Emily Hyle, Sally Coburn, Raynell Lang, Michael J Silverberg, Michael Horberg, Viviane D Lima, M John Gill, Maile Karris, Peter F Rebeiro, Jennifer Thorne, Ashleigh J Rich, Heidi Crane, Mari Kitahata, Anna Rubtsova, Cherise Wong, Sean Leng, View ORCID ProfileVincent C Marconi, Gypsyamber D’Souza, Hyang Nina Kim, Sonia Napravnik, Kathleen McGinnis, Gregory D Kirk, Timothy R Sterling, Richard D Moore, Parastu Kasaie
doi: https://doi.org/10.1101/2022.11.04.22281891
Keri N Althoff
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Cameron Stewart
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Elizabeth Humes
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Lucas Gerace
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Cynthia Boyd
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
2Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
3Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Kelly Gebo
4Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
Amy C Justice
5Yale Schools of Medicine and Public Health, New Haven, Connecticut, USA
6Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
Emily Hyle
7Harvard Medical School and the Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
8Harvard University Center for AIDS Research, Boston, MA, USA
Sally Coburn
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Raynell Lang
9Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Michael J Silverberg
10Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA and Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA
11Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
Michael Horberg
12Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic Permanente Medical Group, Rockville, MD USA
Viviane D Lima
13Epidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada
M John Gill
9Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Maile Karris
14Department of Medicine, University of California San Diego, San Diego, CA, USA
Peter F Rebeiro
15Departments of Medicine and Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA
Jennifer Thorne
16Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Ashleigh J Rich
17Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA
Heidi Crane
18Division of Allergy and Infectious Diseases, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA
Mari Kitahata
18Division of Allergy and Infectious Diseases, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA
Anna Rubtsova
19Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, GA, USA
Cherise Wong
20Division of Worldwide Research and Development, Pfizer Inc., New York, NY, USA
Sean Leng
2Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
Vincent C Marconi
21Division of Infectious Disease, Emory School of Medicine, Atlanta, GA, USA
22Atlanta Veterans Affairs Health Care System, Decatur, GA, USA
Gypsyamber D’Souza
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Hyang Nina Kim
18Division of Allergy and Infectious Diseases, Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA
Sonia Napravnik
23Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kathleen McGinnis
6Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA
Gregory D Kirk
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
4Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
Timothy R Sterling
24Vanderbilt Tuberculosis Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
25Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
Richard D Moore
26Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
Parastu Kasaie
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Data Availability
All mathematical functions and input parameters used in the PEARL agent-based computer simulation model are available at www.PEARLHIVmodel.org.
Posted November 05, 2022.
The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030
Keri N Althoff, Cameron Stewart, Elizabeth Humes, Lucas Gerace, Cynthia Boyd, Kelly Gebo, Amy C Justice, Emily Hyle, Sally Coburn, Raynell Lang, Michael J Silverberg, Michael Horberg, Viviane D Lima, M John Gill, Maile Karris, Peter F Rebeiro, Jennifer Thorne, Ashleigh J Rich, Heidi Crane, Mari Kitahata, Anna Rubtsova, Cherise Wong, Sean Leng, Vincent C Marconi, Gypsyamber D’Souza, Hyang Nina Kim, Sonia Napravnik, Kathleen McGinnis, Gregory D Kirk, Timothy R Sterling, Richard D Moore, Parastu Kasaie
medRxiv 2022.11.04.22281891; doi: https://doi.org/10.1101/2022.11.04.22281891
The projected prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030
Keri N Althoff, Cameron Stewart, Elizabeth Humes, Lucas Gerace, Cynthia Boyd, Kelly Gebo, Amy C Justice, Emily Hyle, Sally Coburn, Raynell Lang, Michael J Silverberg, Michael Horberg, Viviane D Lima, M John Gill, Maile Karris, Peter F Rebeiro, Jennifer Thorne, Ashleigh J Rich, Heidi Crane, Mari Kitahata, Anna Rubtsova, Cherise Wong, Sean Leng, Vincent C Marconi, Gypsyamber D’Souza, Hyang Nina Kim, Sonia Napravnik, Kathleen McGinnis, Gregory D Kirk, Timothy R Sterling, Richard D Moore, Parastu Kasaie
medRxiv 2022.11.04.22281891; doi: https://doi.org/10.1101/2022.11.04.22281891
Subject Area
Subject Areas
- Addiction Medicine (216)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1101)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9782)
- Gastroenterology (481)
- Genetic and Genomic Medicine (2318)
- Geriatric Medicine (223)
- Health Economics (463)
- Health Informatics (1563)
- Health Policy (737)
- Hematology (238)
- HIV/AIDS (507)
- Medical Education (239)
- Medical Ethics (67)
- Nephrology (258)
- Neurology (2148)
- Nursing (134)
- Nutrition (338)
- Oncology (1183)
- Ophthalmology (366)
- Orthopedics (129)
- Otolaryngology (220)
- Pain Medicine (148)
- Palliative Medicine (50)
- Pathology (313)
- Pediatrics (698)
- Primary Care Research (267)
- Public and Global Health (4673)
- Radiology and Imaging (781)
- Respiratory Medicine (624)
- Rheumatology (274)
- Sports Medicine (210)
- Surgery (252)
- Toxicology (43)
- Transplantation (120)
- Urology (94)